- Home
- RMAX vs CATX Comparison
RMAX vs CATX Comparison
Compare RMAX & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RMAX
- CATX
- Stock Information
- Founded
- RMAX 1973
- CATX 1983
- Country
- RMAX United States
- CATX United States
- Employees
- RMAX N/A
- CATX N/A
- Industry
- RMAX Real Estate
- CATX Medical/Dental Instruments
- Sector
- RMAX Finance
- CATX Health Care
- Exchange
- RMAX Nasdaq
- CATX Nasdaq
- Market Cap
- RMAX 161.9M
- CATX 183.2M
- IPO Year
- RMAX 2013
- CATX N/A
- Fundamental
- Price
- RMAX $8.70
- CATX $2.58
- Analyst Decision
- RMAX Sell
- CATX Strong Buy
- Analyst Count
- RMAX 2
- CATX 11
- Target Price
- RMAX $8.75
- CATX $16.30
- AVG Volume (30 Days)
- RMAX 177.3K
- CATX 570.4K
- Earning Date
- RMAX 05-01-2025
- CATX 03-26-2025
- Dividend Yield
- RMAX N/A
- CATX N/A
- EPS Growth
- RMAX N/A
- CATX N/A
- EPS
- RMAX 0.37
- CATX N/A
- Revenue
- RMAX $307,685,000.00
- CATX $1,557,000.00
- Revenue This Year
- RMAX N/A
- CATX N/A
- Revenue Next Year
- RMAX $1.25
- CATX N/A
- P/E Ratio
- RMAX $23.51
- CATX N/A
- Revenue Growth
- RMAX N/A
- CATX N/A
- 52 Week Low
- RMAX $6.94
- CATX $2.32
- 52 Week High
- RMAX $14.31
- CATX $19.10
- Technical
- Relative Strength Index (RSI)
- RMAX 41.50
- CATX 41.08
- Support Level
- RMAX $8.25
- CATX $2.42
- Resistance Level
- RMAX $8.77
- CATX $2.81
- Average True Range (ATR)
- RMAX 0.40
- CATX 0.19
- MACD
- RMAX -0.00
- CATX 0.03
- Stochastic Oscillator
- RMAX 40.60
- CATX 51.00
About RMAX RE/MAX Holdings Inc.
RE/MAX Holdings Inc operates as a franchisor of real estate brokerage services. It recruits and retains agents and sells franchises. The company's operating segments include Real Estate, Mortgage, Marketing Funds, and Others. It generates maximum revenue from the Real Estate segment.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a medical technology and radiopharmaceutical company that is pioneering various treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha emitting isotope 212Pb to deliver powerful radiation specifically to cancer cells via specialized targeting peptides.